SWM
YARW

Spire Wealth Management’s Yarrow Bioscience YARW Stock Holding History

Spire Wealth Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2
Closed -$2K – 2897
2021
Q4 		$2K Buy
+2
New +$2.15K ﹤0.01% 2815
2021
Q2 		– Sell
-19
Closed -$117K – 2987
2021
Q1 		$117K Buy
+19
New +$138K ﹤0.01% 1332

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

Spire Wealth Management's YARW Position: Q1 2022 in Review

Spire Wealth Management sold out of Yarrow Bioscience (YARW) in Q1 2022, closing a stake of 2 shares — an estimated $2K sold.

Spire Wealth Management first reported a position in YARW in Q1 2021 and held it in 2 quarters. The position peaked at $117K in Q1 2021. 41 funds tracked by Wall St. Rank hold YARW as of Q1 2022.

  • Spire Wealth Management reported no remaining Yarrow Bioscience position as of Q1 2022 after selling out during the quarter.
  • Spire Wealth Management sold 2 Yarrow Bioscience shares in Q1 2022, an estimated $2K.
  • Spire Wealth Management first reported a position in Yarrow Bioscience in Q1 2021 and held it in 2 quarters.
  • Spire Wealth Management's Yarrow Bioscience position peaked at $117K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q1 2022.

Based on Spire Wealth Management's 13F filing for Q1 2022, filed 18 Apr 2022.